Supplier profile
Janssen-Cilag GmbH
Every public-sector award we hold for this supplier, across Germany, from 10 Dec 2012 to 20 Apr 2026.
Awards won
29
all time
Attributed value
€4
16 shared, unvalued
Buyers
13
public bodies
Active
2012–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 10 | €2 |
| AOK Baden-Württemberg | 7 | not attributable |
| IKK classic | 2 | not attributable |
| AOK Bayern - Die Gesundheitskasse | 1 | not attributable |
| AOK Rheinland/Hamburg - Die Gesundheitskasse | 1 | not attributable |
| AOK Sachsen - Anhalt | 1 | €1 |
| AOK – Die Gesundheitskasse für Niedersachsen | 1 | not attributable |
| BARMER GEK -Abt. 0830 Vergabestelle- | 1 | not attributable |
| Barmer GEK | 1 | not attributable |
| Brandenburgische Betriebskrankenkasse | 1 | €1 |
What they win
Awards
Showing 1–25 of 29 awards we hold
- Ex-Ante-Transparenzbekanntmachung § 130c Abs. 1 SGB V Tremfya(R) Wirkstoff: Guselkumab ATC-Code: L04AC16 ↗AOK Bayern - Die Gesundheitskasseawarded 20 Apr 2026
- Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V i. V. m. § 130a Abs. 8 SGB V zum Wirkstoff Apalutamid ↗AOK Baden-Württembergshared awardawarded 16 Mar 2026
- Germany – Pharmaceutical products – Arzneimittelrahmenrabattvertrag gemäß § 130c Absatz 1 des Fünften Sozialgesetzbuchs - Tremfya (Wirkstoff: Guselkumab), ausschließlich in der Wirkstärke 200mg, ATC L04AC16 ↗DAK-Gesundheit€1awarded 29 Apr 2025
- Tremfya (Wirkstoff: Guselkumab), ausschließlich in der Wirkstärke 200mg, ATC L04AC16 ↗DAK-Gesundheit€1awarded 25 Apr 2025
- Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zum Wirkstoff Guselkumab ↗AOK Baden-Württembergshared awardawarded 12 Apr 2025
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Ustekinumab, ATC L04AC05 (OBO) für die Zeit 01.08.2024 - 31.07.2025 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 2 Aug 2024
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Ustekinumab, ATC L04AC05 (OBO) für die Zeit 01.08.2024 - 31.07.2025 (zzgl. Verlängerungsoption 1x12 Monate) ↗DAK-Gesundheitshared awardawarded 1 Aug 2024
- Germany – Pharmaceutical products – Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) ↗AOK Baden-Württembergshared awardawarded 12 Jun 2024
- Germany – Pharmaceutical products – Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zum Wirkstoff Apalutamid ↗AOK Baden-Württembergawarded 6 Mar 2024
- Germany-Magdeburg: Pharmaceutical products ↗AOK Sachsen - Anhalt€1awarded 14 Aug 2023
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Golimumab, ATC L04AB06 für die Zeit 01.07.2023 - 30.06.2025 ↗DAK-Gesundheitshared awardawarded 2 Jul 2023
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ustekinumab, ATC L04AC05 für die Zeit 01.07.2023 - 30.06.2025 ↗DAK-Gesundheitshared awardawarded 2 Jul 2023
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Ustekinumab, ATC L04AC05 für die Zeit 01.07.2023 - 30.06.2025 ↗DAK-Gesundheitshared awardawarded 1 Jul 2023
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Golimumab, ATC L04AB06 für die Zeit 01.07.2023 - 30.06.2025 ↗DAK-Gesundheitshared awardawarded 1 Jul 2023
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Guselkumab, ATC L04AC16 für die Zeit 01.12.2022 - 30.11.2024 ↗DAK-Gesundheitshared awardawarded 1 Dec 2022
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Guselkumab, ATC L04AC16 für die Zeit 01.12.2022 - 30.11.2024 ↗DAK-Gesundheitshared awardawarded 1 Dec 2022
- Germany-Eisenhüttenstadt: Pharmaceutical products ↗Brandenburgische Betriebskrankenkasse€1awarded 6 Jul 2018
- Germany-Düsseldorf: Pharmaceutical products ↗AOK Rheinland/Hamburg - Die Gesundheitskasseshared awardawarded 15 Dec 2017
- Medical equipment, pharmaceuticals & personal care — Barmer GEK ↗Barmer GEKawarded 14 Oct 2016
- Medical equipment, pharmaceuticals & personal care — AOK – Die Gesundheitskasse für Niedersachsen ↗AOK – Die Gesundheitskasse für Niedersachsenawarded 4 Oct 2016
- Atazanavir ↗AOK Baden-Württembergshared awardawarded 26 Sept 2016
- Abirateronacetat (ATC-Code: L02BX03) ↗IKK classicawarded 9 May 2016
- Beclometason/Formoterol ↗IKK classicawarded 9 Dec 2015
- Abirateronacetat ↗KKH Kaufmännische Krankenkasseawarded 28 Aug 2015
- ATC-Codes:L04AC05; Ustekinumab; alle Darreichungsformen; alle Wirkstärken; alle Packungsgrößen ↗spectrumK GmbHawarded 10 Jun 2015
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.